338 related articles for article (PubMed ID: 18613885)
21. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
Koc E; Arca E; Kose O; Akar A
J Dermatolog Treat; 2009; 20(1):4-9. PubMed ID: 18677657
[TBL] [Abstract][Full Text] [Related]
22. Topical tacrolimus in the treatment of lichen planus in a child.
Fortina AB; Giulioni E; Tonin E
Pediatr Dermatol; 2008; 25(5):570-1. PubMed ID: 18950405
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
24. Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year.
Van Leent EJ; De Vries HJ; Ebelin ME; Burtin P; Scott G; Bos JD
J Dermatolog Treat; 2007; 18(1):19-22. PubMed ID: 17365262
[TBL] [Abstract][Full Text] [Related]
25. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.
Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M
J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835
[TBL] [Abstract][Full Text] [Related]
27. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of topical calcineurin inhibitors in lichen planus.
Samycia M; Lin AN
J Cutan Med Surg; 2012; 16(4):221-9. PubMed ID: 22784514
[TBL] [Abstract][Full Text] [Related]
29. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood.
Passeron T; Lacour JP; Fontas E; Ortonne JP
Arch Dermatol; 2007 Apr; 143(4):472-6. PubMed ID: 17438179
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of lichen planus with sulfasalazine in 20 patients.
Bauzá A; España A; Gil P; Lloret P; Vázquez Doval FJ
Int J Dermatol; 2005 Feb; 44(2):158-62. PubMed ID: 15689219
[TBL] [Abstract][Full Text] [Related]
31. Steroid-free pimecrolimus (Elidel) for monotherapy of lichen planus.
Lim SJ; Love EW
J Drugs Dermatol; 2004; 3(5):563-4. PubMed ID: 15552611
[TBL] [Abstract][Full Text] [Related]
32. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
[TBL] [Abstract][Full Text] [Related]
33. Facial actinic lichen planus following the Blaschko's lines: successful treatment with topical 0.1% pimecrolimus cream.
Ezzedine K; Simonart T; Vereecken P; Heenen M
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):458-9. PubMed ID: 18624870
[No Abstract] [Full Text] [Related]
34. Belgian observational drug utilization study of pimecrolimus cream 1% in routine daily practice in atopic dermatitis.
De Backer M; Morren MA; Boonen H; Boyden B; Vertruyen A; Lecomte P; Paquay C; Lesaffre E; Lambert J
Dermatology; 2008; 217(2):156-63. PubMed ID: 18525202
[TBL] [Abstract][Full Text] [Related]
35. Response of oral lichen planus to topical tacrolimus in 37 patients.
Byrd JA; Davis MD; Bruce AJ; Drage LA; Rogers RS
Arch Dermatol; 2004 Dec; 140(12):1508-12. PubMed ID: 15611431
[TBL] [Abstract][Full Text] [Related]
36. Nail lichen planus in children: clinical features, response to treatment, and long-term follow-up.
Tosti A; Piraccini BM; Cambiaghi S; Jorizzo M
Arch Dermatol; 2001 Aug; 137(8):1027-32. PubMed ID: 11493095
[TBL] [Abstract][Full Text] [Related]
37. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
38. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
Eichenfield LF; Thaci D; de Prost Y; Puig L; Paul C
Dermatology; 2007; 215 Suppl 1():3-17. PubMed ID: 18174689
[TBL] [Abstract][Full Text] [Related]
39. Erosive mucosal lichen planus and secondary epiphora responding to systemic cyclosporin A treatment.
Boyce AE; Marshman G; Mills RA
Australas J Dermatol; 2009 Aug; 50(3):190-3. PubMed ID: 19659981
[TBL] [Abstract][Full Text] [Related]
40. Limited benefit of topical calcipotriol in lichen planus treatment: a preliminary study.
Bayramgürler D; Apaydin R; Bilen N
J Dermatolog Treat; 2002 Sep; 13(3):129-32. PubMed ID: 12227876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
